Docetaxel
-
Identifiers
CAS number
114977-28-5Molecular formula
C43H53NO14SMILES
CC1=C2[C@H](C(=O)[C@@]3([C@H](C[C@@H]4[C@]([C@H]3[C@@H]([C@@](C2(C)C)(C[C@@H]1OC(=O)[C@@H]([C@H](C5=CC=CC=C5)NC(=O)OC(C)(C)C)O)O)OC(=O)C6=CC=CC=C6)(CO4)OC(=O)C)O)C)O
Safety labels
Irritant
Health -
Odor profile
Fragrance Odorless 61.4% Cooling 26.83% Sweet 25.83% Balsamic 23.46% Mint 23.37% Milky 21.85% Fruity 18.29% Herbal 17.93% Woody 17.73% Clean 17.64% Flavor Bitter 91.18% Bland 31.53% Odorless 31.01% Sweet-like 22.36% Cedarleaf 19.87% Very mild 19.0% Parsley 18.97% Heather 18.85% Broom 18.77% Genet 18.36% Odor impact est.
Low -
Properties
XLogP3-AA
1.6pKa est.
3.57 (weak acid)Molecular weight
807.9 g/molVapor pressure est.
- hPa @ 20°C
- hPa @ 25°C
Evaporation rate
Ultra slowBoiling point est.
1037°CMelting point expt.
- 232 °C
Flash point
- 240.19 ˚C est.
Solubility expt.
- Insoluble
- 1.27e-02 g/L
-
Synonyms
- docetaxel
- 114977-28-5
- Taxotere
- Docetaxel anhydrous
- Docetaxel Kabi
- Docetaxel Winthrop
- Docefrez
- DOCETAXEL MYLAN
- RP-56976
- NSC-628503
- Docetaxel Teva
- Docetaxel Accord
- DOCETAXEL TEVA PHARMA
- BEIZRAY
- BIND 014
- DTXSID0040464
- N-debenzoyl-N-tert-butoxycarbonyl-10-deacetyltaxol
- RP 56976
- N-debenzoyl-N-(tert-butoxycarbonyl)-10-deacetyltaxol
- CKD-810
- SID 530
- 699121PHCA
- NSC 628503
- RP56976
- CHEBI:4672
- N-debenzoyl-N-(tert-butoxycarbonyl)-10-deacetylpaclitaxel
- DTXCID8020464
- [(1S,2S,3R,4S,7R,9S,10S,12R,15S)-4-acetyloxy-1,9,12-trihydroxy-15-[(2R,3S)-2-hydroxy-3-[(2-methylpropan-2-yl)oxycarbonylamino]-3-phenylpropanoyl]oxy-10,14,17,17-tetramethyl-11-oxo-6-oxatetracyclo[11.3.1.03,10.04,7]heptadec-13-en-2-yl] benzoate
- (1S,2S,3R,4S,7R,9S,10S,12R,15S)-4-(acetyloxy)-15-{[(2R,3S)-3-{[(tert-butoxy)carbonyl]amino}-2-hydroxy-3-phenylpropanoyl]oxy}-1,9,12-trihydroxy-10,14,17,17-tetramethyl-11-oxo-6-oxatetracyclo[11.3.1.0^{3,10}.0^{4,7}]heptadec-13-en-2-yl benzoate
- Benzenepropanoic acid, beta-(((1,1-dimethylethoxy)carbonyl)amino)-alpha-hydroxy-, (2aR,4S,4aS,6R,9S,11S,12S,12aR,12bS)-12b-(acetyloxy)-12-(benzoyloxy)-2a,3,4,4a,5,6,9,10,11,12,12a,12b-dodecahydro-4,6,11-trihydroxy-4a,8,13,13-tetramethyl-5-oxo-7,11-methano-1H-cyclodeca(3,4)benz(1,2-b)oxet-9-yl ester, (alphaR,betaS)-
- Benzenepropanoic acid, beta-(((1,1-dimethylethoxy)carbonyl)amino)-alpha-hydroxy-, 12b-(acetyloxy)-12-(benzoyloxy)-2a,3,4,4a,5,6,9,10,11,12,12a,12b-dodecahydro-4,6,11-trihydroxy-4a,8,13,13-tetramethyl-5-oxo-7,11-methano-1H-cyclodeca(3,4)benz(1,2-b)oxet-9-yl ester
- docetaxelum
- Taxceus
- ((1S,2S,3R,4S,7R,9S,10S,12R,15S)-4-acetyloxy-1,9,12-trihydroxy-15-((2R,3S)-2-hydroxy-3-((2-methylpropan-2-yl)oxycarbonylamino)-3-phenylpropanoyl)oxy-10,14,17,17-tetramethyl-11-oxo-6-oxatetracyclo(11.3.1.03,10.04,7)heptadec-13-en-2-yl) benzoate
- (1S,2S,3R,4S,7R,9S,10S,12R,15S)-4-(acetyloxy)-15-(((2R,3S)-3-(((tert-butoxy)carbonyl)amino)-2-hydroxy-3-phenylpropanoyl)oxy)-1,9,12-trihydroxy-10,14,17,17-tetramethyl-11-oxo-6-oxatetracyclo(11.3.1.0^(3,10).0^(4,7))heptadec-13-en-2-yl benzoate
- DOCIVYX
- RefChem:5772
- L01CD02
- (1S,2S,4S,7R,9S,10S,12R,15S)-4-(acetyloxy)-15-(((2R,3S)-3-(((tert-butoxy)(hydroxy)methylidene)amino)-2-hydroxy-3-phenylpropanoyl)oxy)-1,9,12-trihydroxy-10,14,17,17-tetramethyl-11-oxo-6-oxatetracyclo(11.3.1.0^(3,10).0^(4,7))heptadec-13-en-2-yl benzoate
- N Debenzoyl N tert butoxycarbonyl 10 deacetyltaxol
- (1S,2S,3R,4S,7R,9S,10S,12R,15S)-4-(acetyloxy)-15-(((2R,3S)-3-(((tert-butoxy)carbonyl)amino)-2-hydroxy-3-phenylpropanoyl)oxy)-1,9,12-trihydroxy-10,14,17,17-tetramethyl-11-oxo-6-oxatetracyclo(11.3.1.03,10.04,7)heptadec-13-en-2-yl benzoate
- 601-339-2
- Benzenepropanoic acid, beta-(((1,1-dimethylethoxy)carbonyl)amino)-alpha-hydroxy-, (2aR,4S,4aR,6R,9S,11S,12S,12aS,12bS)-12b-(acetyloxy)-12-(benzoyloxy)-2a,3,4,4a,5,6,9,10,11,12,12a,12b-dodecahydro-4,4a,6,11-tetrahydroxy-8,12a,13,13-tetramethyl-5-oxo-7,11-methano-1H-cyclodeca(3,4)benz(1,2-b)oxet-9-yl ester, (alphaR)-, hydrate (1:3)
- 15H5577CQD
- Benzenepropanoic acid, beta-(((1,1-dimethylethoxy)carbonyl)amino)-alpha-hydroxy-, 12b-(acetyloxy)-12-(benzoyloxy)-2a,3,4,4a,5,6,9,10,11,12,12a,12b-dodecahydro-4,6,11-trihydroxy-4a,8,13,13-tetramethyl-5-oxo-7,11-methano-1H-cyclodeca(3,4)benz(1,2-b)oxet-9-ylester, (2aR-(2a-alpha,4-beta,4a-beta,6-beta,9-alpha(alpha-R*,beta-S*),11-alpha,12-alpha,12a-alpha,12b-alpha))-
- Docetaxel (as trihydrate)
- XRP6976
- Docetaxol
- Docetaxel [INN]
- EmDOC
- Docetaxel, anhydrous
- TXL
- Taxotere (TN)
- MFCD00871399
- NSC628503
- CABAZITAXEL METABOLITE (RP56976)
- (2aR,4S,4aS,6R,9S,11S,12S,12aR,12bS)-12b-acetoxy-9-(((2R,3S)-3-((tert-butoxycarbonyl)amino)-2-hydroxy-3-phenylpropanoyl)oxy)-4,6,11-trihydroxy-4a,8,13,13-tetramethyl-5-oxo-2a,3,4,4a,5,6,9,10,11,12,12a,12b-dodecahydro-1H-7,11-methanocyclodeca[3,4]benzo[1,2-b]oxet-12-yl benzoate
- Docetaxel, Trihydrate
- taxotel
- Docetaxolum
- C43H53NO14
- Taxoel
- Docetaxel intermediate
- CAS-114977-28-5
- Docetaxolum [INN-Latin]
- Docecad
- UNII-699121PHCA
- Docetaxel?
- docetaxel 114977-28-5
- HSDB 6965
- XRP-6976L
- ANX-514
- SDP-014
- Anhydrous Docetaxel
- NCGC00181306-01
- NCGC00181306-02
- Taxotere (Aventis)
- CID148124
- N-debenzoyl-N-Boc-10-deacetyl taxol
- Docetaxel (Standard)
- Docetaxel (anhydrous)
- bind-014
- Docetaxel (JAN/INN)
- Anhydrous Docetaxel CRS
- DOCETAXEL [JAN]
- DOCETAXEL [MI]
- CHEMBL92
- DOCETAXEL [HSDB]
- SCHEMBL4419
- Docetaxel - Bio-X trade mark
- GTPL6809
- orb1309994
- BIND 014 [WHO-DD]
- BDBM36351
- HY-B0011R
- SYP-0704A
- ZDZOTLJHXYCWBA-VCVYQWHSSA-
- HMS2089K08
- 114915-20-7
- EX-A1206
- HY-B0011
- MSK10863
- Tox21_112781
- Tox21_113088
- AC-383
- DOCETAXEL ANHYDROUS [WHO-DD]
- EBC-11238
- AKOS015960718
- AKOS024457953
- Tox21_112781_1
- CS-1144
- DB01248
- FD10817
- KS-1452
- Docetaxel, purum, >=97.0% (HPLC)
- NCGC00181306-04
- NCGC00242509-01
- 4-(acetyloxy)-13alpha-({(2R,3S)-3-[(tert-butoxycarbonyl)amino]-2-hydroxy-3-phenylpropanoyl}oxy)-1,7beta,10beta-trihydroxy-9-oxo-5beta,20-epoxytax-11-en-2alpha-yl benzoate
- BD164373
- SY016927
- D4102
- NS00006849
- D07866
- EN300-123047
- AB01273941-01
- AB01273941-02
- Q420436
- 114977-28-5
-
Applications
Docetel (CAS 114977-28-5) is an active pharmaceutical ingredient (API) in the taxane class used in intravenous chemotherapy regimens; in the pharmaceutical industry it is primarily employed for formulation development and manufacturing of parenteral anti-cancer products, typically in combination with appropriate solvents and stabilizers to enable injectable administration; it is handled under strict cytotoxicity controls and is commonly used as a reference material for analytical method development and validation, within regulated production, quality control, and safety systems; its role also includes supplying contract development and manufacturing organizations (CDMOs) in the oncology product development cycle.
gpt-5-nano
-
Solubility @25˚C
Solvent Solubility (g/L) ethanol 132.34 methanol 329.39 isopropanol 70.45 water 0.82 ethyl acetate 57.94 n-propanol 94.84 acetone 218.09 n-butanol 49.7 acetonitrile 51.43 DMF 1106.3 toluene 11.42 isobutanol 40.48 1,4-dioxane 175.93 methyl acetate 101.66 THF 526.3 2-butanone 116.89 n-pentanol 32.98 sec-butanol 40.28 n-hexane 0.54 ethylene glycol 102.48 NMP 896.36 cyclohexane 0.87 DMSO 986.8 n-butyl acetate 21.29 n-octanol 9.5 chloroform 148.61 n-propyl acetate 30.43 acetic acid 742.0 dichloromethane 135.94 cyclohexanone 152.39 propylene glycol 142.72 isopropyl acetate 28.15 DMAc 785.44 2-ethoxyethanol 170.83 isopentanol 23.41 n-heptane 0.46 ethyl formate 86.56 1,2-dichloroethane 71.73 n-hexanol 17.6 2-methoxyethanol 455.99 isobutyl acetate 12.55 tetrachloromethane 12.55 n-pentyl acetate 19.78 transcutol 108.79 n-heptanol 12.17 ethylbenzene 3.9 MIBK 24.83 2-propoxyethanol 138.39 tert-butanol 39.78 MTBE 16.51 2-butoxyethanol 66.1 propionic acid 150.44 o-xylene 5.82 formic acid 438.22 diethyl ether 28.17 m-xylene 5.13 p-xylene 5.06 chlorobenzene 17.33 dimethyl carbonate 138.03 n-octane 0.25 formamide 432.89 cyclopentanone 360.05 2-pentanone 68.08 anisole 20.98 cyclopentyl methyl ether 60.39 gamma-butyrolactone 498.89 1-methoxy-2-propanol 250.79 pyridine 125.71 3-pentanone 50.2 furfural 282.04 n-dodecane 0.2 diethylene glycol 147.41 diisopropyl ether 3.56 tert-amyl alcohol 27.58 acetylacetone 121.81 n-hexadecane 0.22 acetophenone 32.92 methyl propionate 104.67 isopentyl acetate 14.07 trichloroethylene 188.08 n-nonanol 9.08 cyclohexanol 27.78 benzyl alcohol 39.51 2-ethylhexanol 5.78 isooctanol 7.43 dipropyl ether 11.72 1,2-dichlorobenzene 16.18 ethyl lactate 37.65 propylene carbonate 148.4 n-methylformamide 493.54 2-pentanol 18.67 n-pentane 0.77 1-propoxy-2-propanol 64.31 1-methoxy-2-propyl acetate 45.91 2-(2-methoxypropoxy) propanol 39.71 mesitylene 2.27 ε-caprolactone 145.61 p-cymene 1.96 epichlorohydrin 359.54 1,1,1-trichloroethane 40.29 2-aminoethanol 164.04 morpholine-4-carbaldehyde 603.89 sulfolane 698.12 2,2,4-trimethylpentane 0.33 2-methyltetrahydrofuran 110.82 n-hexyl acetate 21.27 isooctane 0.17 2-(2-butoxyethoxy)ethanol 57.17 sec-butyl acetate 12.9 tert-butyl acetate 23.31 decalin 0.38 glycerin 264.78 diglyme 118.36 acrylic acid 234.21 isopropyl myristate 5.34 n-butyric acid 130.32 acetyl acetate 57.06 di(2-ethylhexyl) phthalate 11.07 ethyl propionate 27.58 nitromethane 773.81 1,2-diethoxyethane 23.99 benzonitrile 24.26 trioctyl phosphate 8.26 1-bromopropane 21.91 gamma-valerolactone 642.99 n-decanol 5.54 triethyl phosphate 10.73 4-methyl-2-pentanol 7.89 propionitrile 39.78 vinylene carbonate 160.42 1,1,2-trichlorotrifluoroethane 380.75 DMS 32.26 cumene 2.15 2-octanol 6.27 2-hexanone 34.11 octyl acetate 10.4 limonene 3.42 1,2-dimethoxyethane 168.14 ethyl orthosilicate 9.11 tributyl phosphate 7.78 diacetone alcohol 62.63 N,N-dimethylaniline 16.71 acrylonitrile 83.08 aniline 33.67 1,3-propanediol 173.22 bromobenzene 13.51 dibromomethane 62.39 1,1,2,2-tetrachloroethane 135.82 2-methyl-cyclohexyl acetate 14.85 tetrabutyl urea 15.32 diisobutyl methanol 2.85 2-phenylethanol 25.78 styrene 5.43 dioctyl adipate 14.1 dimethyl sulfate 264.07 ethyl butyrate 16.78 methyl lactate 147.61 butyl lactate 27.85 diethyl carbonate 12.22 propanediol butyl ether 60.75 triethyl orthoformate 13.76 p-tert-butyltoluene 1.96 methyl 4-tert-butylbenzoate 29.14 morpholine 276.13 tert-butylamine 10.33 n-dodecanol 3.39 dimethoxymethane 387.82 ethylene carbonate 112.54 cyrene 104.2 2-ethoxyethyl acetate 41.5 2-ethylhexyl acetate 10.26 1,2,4-trichlorobenzene 28.3 4-methylpyridine 79.43 dibutyl ether 5.63 2,6-dimethyl-4-heptanol 2.85 DEF 119.15 dimethyl isosorbide 72.68 tetrachloroethylene 80.41 eugenol 34.73 triacetin 38.28 span 80 38.77 1,4-butanediol 64.18 1,1-dichloroethane 50.06 2-methyl-1-pentanol 16.85 methyl formate 367.35 2-methyl-1-butanol 25.53 n-decane 0.4 butyronitrile 28.49 3,7-dimethyl-1-octanol 5.46 1-chlorooctane 2.79 1-chlorotetradecane 0.85 n-nonane 0.33 undecane 0.27 tert-butylcyclohexane 0.3 cyclooctane 0.27 cyclopentanol 74.47 tetrahydropyran 81.05 tert-amyl methyl ether 14.96 2,5,8-trioxanonane 70.0 1-hexene 3.21 2-isopropoxyethanol 67.42 2,2,2-trifluoroethanol 226.57 methyl butyrate 41.81 Scent© AI
| Maximum acceptable concentrations in the finished product (%) | |||
|---|---|---|---|
|
Category 1
Products applied to the lips
|
No restriction |
Category 7A
Rinse-off products applied to the hair with some hand contact
|
No restriction |
|
Category 2
Products applied to the axillae
|
No restriction |
Category 7B
Leave-on products applied to the hair with some hand contact
|
No restriction |
|
Category 3
Products applied to the face/body using fingertips
|
No restriction |
Category 8
Products with significant anogenital exposure
|
No restriction |
|
Category 4
Products related to fine fragrance
|
No restriction |
Category 9
Products with body and hand exposure, primarily rinse off
|
No restriction |
|
Category 5A
Body lotion products applied to the body using the hands (palms), primarily leave on
|
No restriction |
Category 10A
Household care products with mostly hand contact
|
No restriction |
|
Category 5B
Face moisturizer products applied to the face using the hands (palms), primarily leave on
|
No restriction |
Category 10B
Household care products with mostly hand contact, including aerosol/spray products (with potential leave-on skin contact)
|
No restriction |
|
Category 5C
Hand cream products applied to the hands using the hands (palms), primarily leave on
|
No restriction |
Category 11A
Products with intended skin contact but minimal transfer of fragrance to skin from inert substrate without UV exposure
|
No restriction |
|
Category 5D
Baby Creams, baby Oils and baby talc
|
No restriction |
Category 11B
Products with intended skin contact but minimal transfer of fragrance to skin from inert substrate with potential UV exposure
|
No restriction |
|
Category 6
Products with oral and lip exposure
|
No restriction |
Category 12
Products not intended for direct skin contact, minimal or insignificant transfer to skin
|
No restriction |